European Commission vs Big Pharma, or profit vs access?
Drug Discovery World
MARCH 29, 2023
On January 31 2023, an internally circulated version of the European Commission’s overhaul of the EU’s pharma legislation was leaked, and published by Politico 1. What are the rNPV effects of forcing pharma companies to pursue new indications requested by third parties, and of opening up the authorisation process to third parties?
Let's personalize your content